|Company Name||# of Hedge Funds||# of Insiders Buying||# of Insiders Selling|
|Array Biopharma Inc (NASDAQ:ARRY)||17||0||0|
|Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)||6||0||0|
|Merrimack Pharmaceuticals Inc (NASDAQ:MACK)||8||0||0|
|Halozyme Therapeutics, Inc. (NASDAQ:HALO)||11||0||0|
|EXACT Sciences Corporation (NASDAQ:EXAS)||10||0||0|
Using the returns explained by the previously mentioned analyses, regular investors must always watch hedge fund and insider trading activity, and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shareholders fit into this picture quite nicely.